RecruitingNot Applicable

Effect of Radiofrequency in the Treatment of de Novo Dyspareunia at 4 to 16 Months Postpartum.

Spain110 participantsStarted 2021-03-18

Plain-language summary

This study evaluates if the application of resistive capacitive monopolar radiofrequency therapy associated with Thiele massage is effective when treating de novo dyspareunia at 4 to 9 months postpartum.

Who can participate

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 4-9 postpartum * de novo dyspareunia after delivery * obstetric injury * Grant informed consent Exclusion Criteria: * radiofrequency contraindications (pacemaker, active infection or pregnancy) * cesarean section * dyspareunia previous to labour * previous vulvo-vaginal pathology * patients with postpartum depression * patients with a pelvic region oncological history

What they're measuring

Change of the baseline Level of pain during penetration and after 5 sessions

Timeframe: Baseline and after 7 weeks

Trial details

NCT IDNCT05417334

SponsorHospital Clinic of Barcelona

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12

Contact for this trial

Carla E Box, PT, Msc

+34 699782115 cebox@clinic.cat

View on ClinicalTrials.gov More Dyspareunia trials